Barclays
SFE

Barclays’s Safeguard Scientifics, Inc. SFE Stock Holding History

Barclays’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,841
Closed -$25K – 4854
2021
Q3 		$25K Buy
2,841
+582
+26% +$4.66K ﹤0.01% 4334
2021
Q2 		$18K Sell
2,259
-14,257
-86% -$97.2K ﹤0.01% 4525
2021
Q1 		$113K Buy
16,516
+10,141
+159% +$73.6K ﹤0.01% 3954
2020
Q4 		$41K Sell
6,375
-2,746
-30% -$17.1K ﹤0.01% 4499
2020
Q3 		$50K Sell
9,121
-2,166
-19% -$12.9K ﹤0.01% 4601
2020
Q2 		$80K Buy
11,287
+4,714
+72% +$29.8K ﹤0.01% 4666
2020
Q1 		$36K Sell
6,573
-13,015
-66% -$116K ﹤0.01% 5407
2019
Q4 		$215K Buy
19,588
+9,750
+99% +$111K ﹤0.01% 4985
2019
Q3 		$111K Sell
9,838
-2,827
-22% -$33.7K ﹤0.01% 5403
2019
Q2 		$153K Sell
12,665
-11,034
-47% -$129K ﹤0.01% 5342
2019
Q1 		$257K Buy
23,699
+5,576
+31% +$56.5K ﹤0.01% 4642
2018
Q4 		$157K Buy
18,123
+9,285
+105% +$81K ﹤0.01% 4749
2018
Q3 		$84K Sell
8,838
-594
-6% -$6.45K ﹤0.01% 5717
2018
Q2 		$120K Buy
9,432
+4,301
+84% +$55.5K ﹤0.01% 5118
2018
Q1 		$63K Buy
5,131
+1,648
+47% +$20K ﹤0.01% 5726
2017
Q4 		$39K Buy
3,483
+2,858
+457% +$36.6K ﹤0.01% 5901
2017
Q3 		$8K Sell
625
-177
-22% -$2.18K ﹤0.01% 6250
2017
Q2 		$9K Buy
802
+371
+86% +$4.37K ﹤0.01% 6095
2017
Q1 		$5K Sell
431
-268
-38% -$3.38K ﹤0.01% 6296
2016
Q4 		$8K Sell
699
-10,537
-94% -$130K ﹤0.01% 5994
2016
Q3 		$146K Buy
11,236
+11,184
+21,508% +$148K ﹤0.01% 4222
2016
Q2 		$1K Buy
+52
New +$697 ﹤0.01% 6189
2015
Q4 		– Sell
-108
Closed -$2K – 6723
2015
Q3 		$2K Sell
108
-287
-73% -$5.15K ﹤0.01% 6394
2015
Q2 		$8K Sell
395
-224
-36% -$4.11K ﹤0.01% 6224
2015
Q1 		$11K Sell
619
-1,057
-63% -$19.6K ﹤0.01% 6194
2014
Q4 		$32K Buy
1,676
+953
+132% +$18.4K ﹤0.01% 6030
2014
Q3 		$14K Sell
723
-337
-32% -$6.65K ﹤0.01% 6710
2014
Q2 		$22K Sell
1,060
-6,157
-85% -$124K ﹤0.01% 6462
2014
Q1 		$159K Buy
7,217
+6,713
+1,332% +$133K ﹤0.01% 5017
2013
Q4 		$10K Buy
504
+295
+141% +$5.22K ﹤0.01% 7012
2013
Q3 		$3K Sell
209
-1,738
-89% -$26.7K ﹤0.01% 7128
2013
Q2 		$32K Buy
+1,947
New +$30.9K ﹤0.01% 6589

Other funds holding SFE

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
CCM
Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return

Barclays's SFE Position: Q4 2021 in Review

Barclays sold out of Safeguard Scientifics, Inc. (SFE) in Q4 2021, closing a stake of 2,841 shares — an estimated $25K sold.

Barclays first reported a position in SFE in Q2 2013 and held it in 32 quarters. The position peaked at $257K in Q1 2019. 63 funds tracked by Wall St. Rank hold SFE as of Q4 2021.

  • Barclays reported no remaining Safeguard Scientifics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 2,841 Safeguard Scientifics, Inc. shares in Q4 2021, an estimated $25K.
  • Barclays first reported a position in Safeguard Scientifics, Inc. in Q2 2013 and held it in 32 quarters.
  • Barclays's Safeguard Scientifics, Inc. position peaked at $257K in Q1 2019.
  • 63 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.